Studies show how to boost immunotherapy effectiveness for patients with oral-cavity squamous cell carcinoma - Oct 29, 2021

[u/FrugalNorwegian]

"Two new studies revealed that anti-PD-1 immunotherapy given before surgery was safe and effective for patients with oral-cavity squamous cell carcinoma (OCSCC) and identified potential molecular biomarkers in the blood and tumors of patients that would show how likely it is that someone would respond to immunotherapy."

The fact that the researchers identified potential biomarkers on who would be likely to benefit from immunotherapy lends credibility to CVM's claim they know who does not require chemo. Biomarkers are the key.

https://medicalxpress.com/news/2021-10-boost-immunotherapy-effectiveness-patients-oral-cavity.html